| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/06/1996 | CA2206511A1 Compositions for the treatment of parasitic and fungal infections |
| 06/06/1996 | CA2206449A1 In vitro t-lymphopoiesis system |
| 06/06/1996 | CA2206441A1 Cd40 associated proteins |
| 06/05/1996 | EP0714513A1 Molecular clones producing recombinant dna antigens of the hards virus |
| 06/05/1996 | EP0714305A1 Composition and method for stimulation of reproductive performance |
| 06/05/1996 | EP0408770B1 New sulfated polysaccharide, pharmaceutically acceptable salts thereof, preparation thereof, and drug containing the same as active ingredient |
| 06/05/1996 | CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy |
| 06/05/1996 | CN1123836A Process of scorpion soaking wine |
| 06/05/1996 | CN1123703A Jade health-care pad with Chinese medicines |
| 06/05/1996 | CN1123691A Zengzhiling capsule for intelligence development and its production |
| 06/05/1996 | CN1123690A Naoxuekang capsule for curing cerebrovascular disease and its production |
| 06/05/1996 | CN1123689A Xiansukang capsule for curing epilepsy and its production |
| 06/05/1996 | CN1123671A Medicine for curing nephritis |
| 06/05/1996 | CN1123669A Capsule for protecting liver and eliminating tumor |
| 06/05/1996 | CN1123666A Injection for curing cystic and its producing technique |
| 06/05/1996 | CN1123636A Microorgan drink and its production |
| 06/05/1996 | CN1123635A Pearl drink and its production |
| 06/05/1996 | CN1123634A Snail powder and its technical line |
| 06/05/1996 | CN1031948C Process for preparing antibiotic GE2270 |
| 06/04/1996 | US5523292 Method of preventing restenosis following coronary angioplasty |
| 06/04/1996 | US5523287 Thrombin-inhibitory protein from assassin bugs |
| 06/04/1996 | US5523096 Removal of selected factors from whole blood or its components |
| 05/30/1996 | WO1996016179A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
| 05/30/1996 | WO1996016162A1 Novel embryonic cell populations and methods to isolate such populations |
| 05/30/1996 | WO1996016070A1 Substance mk7634, process for production thereof, and anthelminthic containing said substance |
| 05/30/1996 | WO1996015849A1 Method of drying blood plasma |
| 05/30/1996 | WO1996015813A1 Cell compositions for use in transplantation and ex vivo gene therapy |
| 05/30/1996 | WO1996015812A1 Use of neuregulins as modulators of cellular communication |
| 05/30/1996 | WO1996015808A1 Method for making a medicament for treating secondary immunodeficiency |
| 05/30/1996 | WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 05/30/1996 | WO1996015783A1 Method for topical treatment of androgenic alopecia |
| 05/30/1996 | WO1996015758A2 Methods for stimulating erythropoiesis using thrombopoietin |
| 05/30/1996 | WO1996010427A3 Cellular attachment to trans-epithelial appliances |
| 05/30/1996 | CA2205835A1 Method for topical treatment of androgenic alopecia |
| 05/30/1996 | CA2205593A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
| 05/30/1996 | CA2204850A1 Use of neuregulins as modulators of cellular communication |
| 05/29/1996 | EP0713881A2 Use of vWF containing concentrate as combination therapy with antithrombotics and fibrinolytics |
| 05/29/1996 | EP0431129B1 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 05/29/1996 | CN1123557A Process for obtaining high-purity egg oil and use thereof |
| 05/29/1996 | CN1123153A Queen-scorpion extract |
| 05/29/1996 | CN1123148A "Shencao" plaster for releasing ache resulted from cancer |
| 05/28/1996 | US5521155 Antibiotic active against grampositive bacteria |
| 05/28/1996 | US5521079 Microcapsule generating system containing an air knife and method of encapsulating |
| 05/28/1996 | US5520885 Fibrinogen processing apparatus, method and container |
| 05/26/1996 | CA2136698A1 Resin compositions and methods for their use |
| 05/26/1996 | CA2136697A1 Resin compositions and methods for their use |
| 05/23/1996 | WO1996015238A1 Targeted t lymphocytes |
| 05/23/1996 | WO1996015229A1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| 05/23/1996 | WO1996015228A1 Method of purifying a population of cells enriched for hematopoietic stem cells |
| 05/23/1996 | WO1996015226A1 Regulation of neural stem cell proliferation |
| 05/23/1996 | WO1996015224A1 In vitro induction of dopaminergic cells |
| 05/23/1996 | WO1996015150A1 Process for purifying factor viii |
| 05/23/1996 | WO1996015131A1 Macrocyclic lactone compounds and their production process |
| 05/23/1996 | WO1996014877A1 Novel tumor suppressor gene, hic-1 |
| 05/23/1996 | WO1996014868A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 05/23/1996 | WO1996014863A1 Suppression of proteolytic activity by dysfunctional protease formation |
| 05/23/1996 | WO1996014853A1 Intrathymic stem cell implantation |
| 05/23/1996 | WO1996014748A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS |
| 05/23/1996 | WO1996014746A1 A method of inducing resistance to tumor growth |
| 05/23/1996 | WO1996014741A2 Long-term blood component storage system and method |
| 05/23/1996 | WO1996014740A1 Synthetic media for blood components |
| 05/23/1996 | WO1996010580A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 05/23/1996 | WO1996009831A3 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 05/23/1996 | CA2205414A1 Novel tumor suppressor gene, hic-1 |
| 05/23/1996 | CA2204886A1 Amelioration of human erectile dysfunction by treatment with inos, and related nos agents |
| 05/23/1996 | CA2204629A1 In vitro induction of dopaminergic cells |
| 05/23/1996 | CA2204597A1 Suppression of proteolytic activity by dysfunctional protease formation |
| 05/23/1996 | CA2204145A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 05/23/1996 | CA2203934A1 Targeted t lymphocytes |
| 05/23/1996 | CA2203525A1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| 05/22/1996 | EP0712936A1 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 05/22/1996 | EP0712574A2 Use of D,L-alpha-lipoic acid, its enantiomers and/or its derivatives as additive for erythrocyte liquid preserves and cryopreserves for homologous and autologous erythrocyte concentrates |
| 05/22/1996 | EP0502081B1 Proliferative action of leukaemia inhibitory factor on satellite cells |
| 05/22/1996 | CN1122832A Method for prepn. of medicinal wine-"Panjijiu" |
| 05/22/1996 | CN1122711A Hepatitis virus inhibitor and prepn. method thereof |
| 05/22/1996 | CN1122694A Water soluble nacre powder series products and prepn. method |
| 05/22/1996 | CN1122693A Medical use of RNA from poultry embryo |
| 05/22/1996 | CN1031815C Medicine for curing lupus, and method for preparing same |
| 05/21/1996 | US5519117 Polypeptide sequences as anticarcinogenic agents |
| 05/21/1996 | US5518928 Leukocyte differentiation method |
| 05/21/1996 | US5518915 On a biocompatible framework |
| 05/17/1996 | WO1996014412A2 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 05/17/1996 | WO1996014409A1 Production of recombinant peptides as natural hydrophobic peptide analogues |
| 05/17/1996 | WO1996014401A1 Transgenic organisms and their uses |
| 05/17/1996 | WO1996014399A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease |
| 05/17/1996 | WO1996014398A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 05/17/1996 | WO1996014397A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 05/17/1996 | WO1996014394A1 Human dna ligase iii |
| 05/17/1996 | WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 05/17/1996 | WO1996013974A1 In vitro tissue and organ equivalent models |
| 05/17/1996 | WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 05/17/1996 | CA2204869A1 In vitro tissue and organ equivalent models |
| 05/17/1996 | CA2204511A1 Production of recombinant peptides as natural hydrophobic peptide analorues |
| 05/17/1996 | CA2204429A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease |
| 05/17/1996 | CA2204428A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 05/17/1996 | CA2204427A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 05/17/1996 | CA2203935A1 Transgenic organisms and their uses |
| 05/15/1996 | EP0711552A1 Dermatologic compositions containing wool wax acids and fatty acid glycerides against superinfections |
| 05/15/1996 | EP0711503A2 Milk fortified with GLA and/or DGLA |
| 05/15/1996 | EP0711355A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |